Helsing

Retained excerpt

Munich-based defense startup Helsing secured a $1.8 billion Series E from investors including Dragoneer Investment Group, Lightspeed and General Catalyst at an $18 billion valuation. Shanghai-based biotech Drug Farm, which develops therapies for metabolic and autoimmune diseases, raised $55 million in a Series D led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund Partnership Enterprise. Valarian, a London-based startup developing AI and data infrastructure software for governments, raised a $50 million Series A led by NEA. London-based functional coffee and matcha brand Reformed received a $22 million Series A led by Iris Ventures. Seattle-based Augmodo, which makes AI-powered wearable devices for warehouses, facility maintenance and delivery operations, raised $21 million led by TQ Ventures, valuing the company at $350 million.

This limited excerpt is retained to explain the source trail. Rights remain with the original publisher.